Pharmacogenomic Prediction of Ribavirin-Induced Hemolytic Anemia in Patients Treated for Hepatitis C Infection

Pharmacogenomic Prediction of Ribavirin-Induced Hemolytic Anemia in Patients Treated for Hepatitis C Infection

10.1016/j.vascn.2017.09.002

Saved in:

Bibliographic Details
Main Authors:	Abel, Shawna, Aminkeng, Folefac, Kowalec, Kaarina, Drogemoller, Britt, Wright, Galen, Bader, Rachel, Stortz, Jessica, Yoshida, Eric, Lee, Sam, Al-Judaibi, Bandar, Kim, Richard, Tam, Edward, Ramji, Alnoor, Ross, Colin, Carleton, Bruce
Other Authors:	MEDICINE
Format:	Conference or Workshop Item
Published:	ELSEVIER SCIENCE INC 2022
Subjects:	Science & Technology Life Sciences & Biomedicine Pharmacology & Pharmacy Toxicology
Online Access:	https://scholarbank.nus.edu.sg/handle/10635/235046
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore

Similar Items

Multifactorial Prediction of Anthracycline-Induced Cardiotoxicity in Childhood Cancer: 10 Years of Active Surveillance and Pharmacogenomics Studies at the Canadian Pharmacogenomics Network for Drug Safety
by: Aminkeng, Folefac, et al.
Published: (2022)

Pharmacogenomics of Vincristine-Induced Peripheral Neuropathy Implicates Pharmacokinetic and Inherited Neuropathy Genes
by: Wright, Galen EB, et al.
Published: (2022)

An initial health economic evaluation of pharmacogenomic testing in patients treated for childhood cancer with anthracyclines
by: Dionne, Francois, et al.
Published: (2022)

Pharmacogenomic screening for anthracycline-induced cardiotoxicity in childhood cancer
by: Aminkeng, Folefac, et al.
Published: (2022)

Pharmacogenomic Prediction of Cisplatin-Induced Nephrotoxicity in Patients Treated for Childhood Cancer
by: Medeiros, Mara, et al.
Published: (2022)

The emerging era of pharmacogenomics: current successes, future potential, and challenges
by: Lee, JW, et al.
Published: (2022)

Genome-wide Scan Identifies Association Between an Interferon Regulatory Factor Variant and Interferon-beta Induced Liver Injury in Multiple Sclerosis Patients
by: Kowalec, Kaarina, et al.
Published: (2022)

Pharmacogenomic diversity in Singaporean populations and Europeans
by: Brunham, LR, et al.
Published: (2022)

Common variation near IRF6 is associated with IFN-beta-induced liver injury in multiple sclerosis
by: Kowalec, Kaarina, et al.
Published: (2022)

Pharmacogenomic prediction of immune-related adverse events from immune checkpoint inhibitors among Asian patients
by: Huang, Yiqing, et al.
Published: (2022)

Pharmacogenomics and Personalized Medicine
by: Prastiya Indra Gunawan, Prastiya

Editorial: Pharmacogenomics and ethnicity: Prevalence and clinical significance of pharmacogenomic biomarkers in indigenous and other populations
by: Patrinos G.P.
Published: (2023)

Inhibition of dengue virus replication by mycophenolic acid and ribavirin
by: Ratree Takhampunya, et al.
Published: (2018)

Effect of dietary purines on the pharmacokinetics of orally administered ribavirin
by: Li, L., et al.
Published: (2011)

Clinical pharmacogenomics of thiopurine S-methyltransferase.
by: Zhou, S.
Published: (2014)

Clinical Applications of Pharmacogenomics of Warfarin
by: CHAN SZE LING
Published: (2013)

Genetic Variation in SLC16A5 Confers Protection from Cisplatin-Induced Ototoxicity in Adult Testicular Cancer Patients
by: Drogemoller, Britt, et al.
Published: (2022)

APPROACHES TO PHARMACOGENOMICS TRANSLATION IN PUBLIC HEALTH
by: TAN-KOI WEI CHUEN
Published: (2017)

Advances and challenges in fluoropyrimidine pharmacogenomics and pharmacogenetics
by: Soong, R., et al.
Published: (2014)

Pharmacogenomic Prediction of Bleomycin-Induced Pneumonitis in South East Asian Hodgkin Lymphoma Patients
by: Lee, Joanne Shu Xian, et al.
Published: (2022)

Identification and functional validation of novel pharmacogenomic variants using a next-generation sequencing-based approach for clinical pharmacogenomics
by: Stavroula Siamoglou, et al.
Published: (2022)

Identification and functional validation of novel pharmacogenomic variants using a next-generation sequencing-based approach for clinical pharmacogenomics
by: Siamoglou S.
Published: (2023)

Inhibition of dengue virus production and cytokine/chemokine expression by ribavirin and compound A
by: Thidarath Rattanaburee, et al.
Published: (2018)

Combination therapy with amantadine, oseltamivir and ribavirin for influenza A infection: Safety and pharmacokinetics
by: Sachiko Seo, et al.
Published: (2018)

Combination therapy with amantadine, oseltamivir and ribavirin for influenza A infection: Safety and pharmacokinetics
by: Seo, S., et al.
Published: (2016)

Prevalence of pharmacogenomic variants in 100 pharmacogenes among Southeast Asian populations under the collaboration of the Southeast Asian Pharmacogenomics Research Network (SEAPharm)
by: Chakkaphan Runcharoen, et al.
Published: (2022)

Editorial: Brief research reports in pharmacogenetics and pharmacogenomics: 2022
by: Sessa F.
Published: (2023)

Pharmacogenomics in Asians: Differences and similarities with other human populations
by: Biswas M.
Published: (2023)

Patogenisitas dan sensitivitas Staphylococcus epidermidis Galur Hemolytic dan Galur NonHemolytic Isolat Blitar pada Ikan Mas (Cyprinus carpio)
by: , SOKHIB, et al.
Published: (2004)

Autoimmune hemolytic anemia; its natural history and management
by: Kueh, Y.K., et al.
Published: (2014)

Anti-E as a cause of hemolytic disease of the newborn
by: Cheepsattayakorn R., et al.
Published: (2014)

The beta-hemolytic streptococcal pharyngeal carriers in school children
by: S. Danchaivijitr, et al.
Published: (2018)

Reticulocyte analysis in iron deficiency anemia and hemolytic anemia
by: Punnee Butthep
Published: (2018)

Immune-mediated hemolytic anemia in pediatric renal transplantation
by: Anirut Pattaragarn, et al.
Published: (2018)

Pharmacogenomic associations of adverse drug reactions in asthma: systematic review and research prioritisation
by: King, Charlotte, et al.
Published: (2022)

Implementing Pharmacogenomics at Your Institution: Establishment and Overcoming Implementation Challenges
by: M. J. Arwood, et al.
Published: (2018)

Clinical pharmacogenomics implementation in Thailand: a dream come true
by: Sukasem C.
Published: (2023)

Efficacy of pegylated interferon and ribavirin for the treatment of chronic hepatitis C, genotype 3 patients in Thailand
by: Watcharasak Chotiyaputta, et al.
Published: (2019)

Antiviral mechanism of Nitric oxide, Mycophenolic acid and Ribavirin on dengue virus type 2 infection
by: Ratree Takhampunya
Published: (2023)

Detection of immune-mediated hemolytic anemia in cats by flow cytometry
by: Parkorn Limlenglert
Published: (2012)